{"id":"lynestrenol","rwe":[{"pmid":"41723577","year":"2026","title":"Comparison of Substances in Combined Oral Contraceptives Used in Acne Vulgaris, Hirsutism, Migraine, and Dysmenorrhea.","finding":"","journal":"Medical science monitor : international medical journal of experimental and clinical research","studyType":"Clinical Study"},{"pmid":"40826925","year":"2025","title":"Maternal medication use in pregnancy and offspring ASD risk: A prescription-wide, target-informed study.","finding":"","journal":"European psychiatry : the journal of the Association of European Psychiatrists","studyType":"Clinical Study"},{"pmid":"39589032","year":"2024","title":"The effects of gender-affirming testosterone therapy in transgender men on the development of acne, acne severity and the relationship with clinical parameters: a three-year follow-up study.","finding":"","journal":"European journal of dermatology : EJD","studyType":"Clinical Study"},{"pmid":"37977437","year":"2024","title":"Progestins as a Contributing Factor to Hepatocellular Adenoma: A Case Series and Literature Review.","finding":"","journal":"Journal of pediatric and adolescent gynecology","studyType":"Clinical Study"},{"pmid":"37724475","year":"2023","title":"Protein C and protein S deficiencies are associated with increased risk of deep vein thrombosis in pregnant women using oral contraceptives.","finding":"","journal":"Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis","studyType":"Clinical Study"}],"tags":[{"label":"lynestrenol","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"G03AA03","category":"atc"},{"label":"Active","category":"status"},{"label":"Contraceptive Agents","category":"pharmacology"},{"label":"Contraceptive Agents, Female","category":"pharmacology"},{"label":"Contraceptive Agents, Hormonal","category":"pharmacology"},{"label":"Contraceptives, Oral, Hormonal","category":"pharmacology"},{"label":"Contraceptives, Oral, Synthetic","category":"pharmacology"},{"label":"Reproductive Control Agents","category":"pharmacology"}],"phase":"marketed","safety":{"safetySignals":[{"llr":155.051,"date":"","count":19,"signal":"Macrocephaly","source":"DrugCentral FAERS","actionTaken":"Reported 19 times (LLR=155)"},{"llr":147.362,"date":"","count":20,"signal":"Pyloric stenosis","source":"DrugCentral FAERS","actionTaken":"Reported 20 times (LLR=147)"}],"commonSideEffects":[]},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=LYNESTRENOL","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:00:29.326347+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:00:35.889517+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=LYNESTRENOL","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:00:36.145786+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2107431/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:00:36.838814+00:00"}},"allNames":"orgametril","offLabel":[],"synonyms":["lynestrenol","ethynylestrenol","linestrenol","orgametril","orgametrol"],"timeline":[],"approvals":[],"brandName":"Orgametril","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"lynestrenol","explanation":"","oneSentence":"","technicalDetail":"Lynestrenol is a synthetic progestogen that binds to progesterone receptors in the body, triggering a series of downstream effects that help to regulate the menstrual cycle and prevent pregnancy."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1620","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=LYNESTRENOL","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=LYNESTRENOL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T12:27:27.934355","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:00:38.439797+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"ethinylestradiol","drugSlug":"ethinylestradiol","fdaApproval":"1943-06-25","relationship":"same-class"},{"drugName":"etynodiol","drugSlug":"etynodiol","fdaApproval":"1966-03-23","relationship":"same-class"},{"drugName":"megestrol acetate","drugSlug":"megestrol-acetate","fdaApproval":"1971-08-18","genericCount":10,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"norethisterone","drugSlug":"norethisterone","fdaApproval":"1962-05-21","relationship":"same-class"},{"drugName":"levonorgestrel","drugSlug":"levonorgestrel","fdaApproval":"1968-04-16","patentExpiry":"Sep 7, 2040","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"medroxyprogesterone","drugSlug":"medroxyprogesterone","fdaApproval":"1959-06-18","genericCount":16,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"desogestrel","drugSlug":"desogestrel","fdaApproval":"1992-12-10","relationship":"same-class"},{"drugName":"norgestimate","drugSlug":"norgestimate","fdaApproval":"1989-12-29","relationship":"same-class"},{"drugName":"drospirenone","drugSlug":"drospirenone","fdaApproval":"2019-05-23","patentExpiry":"Jun 28, 2031","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"lynestrenol","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"ethinylestradiol","brandName":"ethinylestradiol","genericName":"ethinylestradiol","approvalYear":"1943","relationship":"same-class"},{"drugId":"etynodiol","brandName":"etynodiol","genericName":"etynodiol","approvalYear":"1966","relationship":"same-class"},{"drugId":"megestrol-acetate","brandName":"megestrol acetate","genericName":"megestrol acetate","approvalYear":"1971","relationship":"same-class"},{"drugId":"norethisterone","brandName":"norethisterone","genericName":"norethisterone","approvalYear":"1962","relationship":"same-class"},{"drugId":"levonorgestrel","brandName":"levonorgestrel","genericName":"levonorgestrel","approvalYear":"1968","relationship":"same-class"},{"drugId":"medroxyprogesterone","brandName":"medroxyprogesterone","genericName":"medroxyprogesterone","approvalYear":"1959","relationship":"same-class"},{"drugId":"desogestrel","brandName":"desogestrel","genericName":"desogestrel","approvalYear":"1992","relationship":"same-class"},{"drugId":"norgestimate","brandName":"norgestimate","genericName":"norgestimate","approvalYear":"1989","relationship":"same-class"},{"drugId":"drospirenone","brandName":"drospirenone","genericName":"drospirenone","approvalYear":"2019","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT00647933","phase":"PHASE1","title":"An Open-label, Single Center Trial to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Org 36286 (P07004)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2000-06","conditions":["Infertility"],"enrollment":24,"completionDate":"2000-12"},{"nctId":"NCT02715232","phase":"PHASE4","title":"Effects of Sex Steroids on the Serotonin System","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2017-02-06","conditions":["Gender Dysphoria"],"enrollment":92,"completionDate":"2020-12"},{"nctId":"NCT01292785","phase":"","title":"Effects of Sex Steroid Hormones on Human Brain Function, Structure and Connectivity","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2011-01","conditions":["Gender Identity Disorder"],"enrollment":80,"completionDate":"2015-04"},{"nctId":"NCT01065220","phase":"PHASE4","title":"Sex Steroids and the Serotonin Transporter","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2010-02","conditions":["Transsexualism"],"enrollment":32,"completionDate":"2014-01"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NUI":"N0000167400","NDDF":"005279","UNII":"N2Z8ALG4U5","CHEBI":"CHEBI:31790","INN_ID":"1222","RXNORM":"6529","UMLSCUI":"C0024321","chemblId":"CHEMBL2107431","ChEMBL_ID":"CHEMBL2107431","KEGG_DRUG":"D01580","DRUGBANK_ID":"DB12474","PUBCHEM_CID":"5857","SNOMEDCT_US":"326328004","MESH_DESCRIPTOR_UI":"D008234"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"30%"},"publicationCount":539,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"G03AA03","allCodes":["G03AA03","G03AB02","G03AC02","G03DC03","G03FA07","G03FB02"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026 Feb 22","pmid":"41723577","title":"Comparison of Substances in Combined Oral Contraceptives Used in Acne Vulgaris, Hirsutism, Migraine, and Dysmenorrhea.","journal":"Medical science monitor : international medical journal of experimental and clinical research"},{"date":"2025 Aug 19","pmid":"40826925","title":"Maternal medication use in pregnancy and offspring ASD risk: A prescription-wide, target-informed study.","journal":"European psychiatry : the journal of the Association of European Psychiatrists"},{"date":"2024 Oct 1","pmid":"39589032","title":"The effects of gender-affirming testosterone therapy in transgender men on the development of acne, acne severity and the relationship with clinical parameters: a three-year follow-up study.","journal":"European journal of dermatology : EJD"},{"date":"2024 Apr","pmid":"37977437","title":"Progestins as a Contributing Factor to Hepatocellular Adenoma: A Case Series and Literature Review.","journal":"Journal of pediatric and adolescent gynecology"},{"date":"2023 Oct 1","pmid":"37724475","title":"Protein C and protein S deficiencies are associated with increased risk of deep vein thrombosis in pregnant women using oral contraceptives.","journal":"Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"withdrawn","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:00:38.439797+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}